Hims & hers health, inc. (hims) shares crash after novo nordisk cancels partnership over "deceptive" marketing of wegovy, faces investor scrutiny- hagens berman

San francisco , june 25, 2025 /prnewswire/ -- on june 23, 2025 investors in hims & hers health, inc. (nyse: hims) saw the price of their shares crash over 30% after novo nordisk announced that it terminated its collaboration with the telehealth company due to concerns about hims & hers' sales and "deceptive" marketing of the weight loss drug wegovy®. this news has prompted national shareholders rights firm hagens berman to open an investigation into possible violations of the securities laws.
HIMS Ratings Summary
HIMS Quant Ranking